Seth van Voorhees
Insider Reports History
- Location
- Short Hills, NJ
- Signature
- /s/ Seth Van Voorhees
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Seth van Voorhees:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PDS Biotechnology Corp | Chief Financial Officer | Common Stock | 17,647 | $172,588 | $9.78 | 15 Jun 2021 | Direct |
| NRX Pharmaceuticals, Inc. | CHIEF FINANCIAL OFFICER | Common Stock, par value $0.001 per share | 46,337 | $14,823 | $0.3199 | 16 Dec 2022 | Direct |
| NRX Pharmaceuticals, Inc. | CHIEF FINANCIAL OFFICER | Common Stock, par value $0.001 per share | 16,377 | $5,239 | $0.3199 | 25 Nov 2022 | Shares purchased though 401(k) plan |
Insider Reports Filed by Seth van Voorhees
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals, Inc. | 16 Dec 2022 | 1 | +$33,000 | 4 | CHIEF FINANCIAL OFFICER | 19 Dec 2022, 06:09 |
| NRXP | NRX Pharmaceuticals, Inc. | 25 Nov 2022 | 3 | +$18,215 | 4/A | CHIEF FINANCIAL OFFICER | 19 Dec 2022, 06:08 |
| NRXP | NRX Pharmaceuticals, Inc. | 13 Jun 2022 | 0 | $0 | 3 | Chief Financial Officer | 29 Jun 2022, 18:14 |
| PDSB | PDS Biotechnology Corp | 15 Jun 2021 | 1 | +$150,000 | 4 | Chief Financial Officer | 17 Jun 2021, 18:52 |